Advertisement
Screener

Alamar Biosciences, Inc. (ALMR) Payments to Acquire Short-term Investments

Alamar Biosciences, Inc. Payments to Acquire Short-term Investments

Alamar Biosciences, Inc. (ALMR) reported Payments to Acquire Short-term Investments of $117.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-08-11

  • 2026-06-30: Payments to Acquire Short-term Investments 6 month $117.05M.
  • 2025-06-30: Payments to Acquire Short-term Investments 6 month $4.94M.
Period endPayments to Acquire Short-term Investments 6 month
2026-06-30$117.05M
10-Q · filed 2026-08-11
2025-06-30$4.94M
10-Q · filed 2026-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42